Coty Valuation

Is 0I4A undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0I4A when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0I4A ($9.35) is trading below our estimate of fair value ($26.7)

Significantly Below Fair Value: 0I4A is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0I4A?

Other financial metrics that can be useful for relative valuation.

0I4A key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2x
Enterprise Value/EBITDA12x
PEG Ratio3.7x

Price to Earnings Ratio vs Peers

How does 0I4A's PE Ratio compare to its peers?

The above table shows the PE ratio for 0I4A vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average20.4x
HLN Haleon
31.4x12.5%UK£34.1b
ULVR Unilever
21.3x5.3%UK£118.4b
W7L Warpaint London
23.6x11.5%UK£404.3m
REVB Revolution Beauty Group
5.3x-34.7%UK£56.2m
0I4A Coty
106.6x29.0%US$7.8b

Price-To-Earnings vs Peers: 0I4A is expensive based on its Price-To-Earnings Ratio (106.6x) compared to the peer average (20.4x).


Price to Earnings Ratio vs Industry

How does 0I4A's PE Ratio compare vs other companies in the European Personal Products Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a7.1%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a7.1%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: 0I4A is expensive based on its Price-To-Earnings Ratio (106.6x) compared to the European Personal Products industry average (21x).


Price to Earnings Ratio vs Fair Ratio

What is 0I4A's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0I4A PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio106.6x
Fair PE Ratio30.4x

Price-To-Earnings vs Fair Ratio: 0I4A is expensive based on its Price-To-Earnings Ratio (106.6x) compared to the estimated Fair Price-To-Earnings Ratio (30.4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0I4A forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$9.35
US$12.60
+34.7%
14.6%US$17.00US$10.00n/a20
Oct ’25US$9.21
US$12.55
+36.2%
14.9%US$17.00US$10.00n/a20
Sep ’25US$9.22
US$12.67
+37.4%
13.7%US$17.00US$10.00n/a20
Aug ’25US$9.65
US$12.82
+32.9%
11.9%US$16.50US$11.00n/a20
Jul ’25US$10.02
US$13.17
+31.4%
12.2%US$16.50US$11.00n/a20
Jun ’25US$10.30
US$13.27
+28.8%
11.3%US$16.50US$11.00n/a20
May ’25US$11.22
US$13.35
+19.0%
11.6%US$17.50US$11.00n/a21
Apr ’25US$11.92
US$13.57
+13.9%
12.2%US$17.50US$11.00n/a20
Mar ’25US$12.59
US$13.53
+7.4%
12.7%US$17.50US$10.50n/a20
Feb ’25US$12.20
US$13.15
+7.8%
11.9%US$17.00US$10.50n/a20
Jan ’25US$12.42
US$12.75
+2.6%
13.6%US$17.00US$10.00n/a20
Dec ’24US$11.53
US$12.65
+9.7%
13.6%US$17.00US$10.00n/a20
Nov ’24US$9.20
US$12.78
+38.9%
12.2%US$15.00US$10.00n/a18
Oct ’24US$11.00
US$13.42
+22.0%
10.5%US$16.00US$11.00US$9.2116
Sep ’24US$11.69
US$13.17
+12.7%
9.7%US$15.00US$11.00US$9.2216
Aug ’24US$11.91
US$13.57
+13.9%
10.0%US$17.00US$11.50US$9.6515
Jul ’24US$12.33
US$13.30
+7.9%
10.8%US$16.00US$11.50US$10.0215
Jun ’24US$11.07
US$13.23
+19.6%
11.1%US$16.00US$11.50US$10.3015
May ’24US$11.72
US$12.62
+7.7%
14.9%US$16.00US$8.25US$11.2215
Apr ’24US$12.04
US$11.95
-0.7%
16.6%US$15.00US$8.25US$11.9215
Mar ’24US$11.26
US$11.88
+5.5%
15.9%US$15.00US$8.25US$12.5915
Feb ’24US$9.93
US$10.84
+9.2%
20.1%US$15.00US$7.00US$12.2014
Jan ’24US$8.51
US$10.27
+20.8%
24.3%US$15.00US$7.00US$12.4215
Dec ’23US$7.97
US$10.20
+28.1%
24.4%US$15.00US$7.00US$11.5315
Nov ’23US$6.89
US$10.34
+50.1%
22.0%US$15.00US$7.00US$9.2015
Oct ’23US$6.40
US$10.65
+66.5%
18.6%US$15.00US$8.00US$11.0015

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies